CCL20/MIP3α is a novel Anti-HIV-1 molecule of the human female reproductive tract

American Journal of Reproductive Immunology

Volumn 62, Issue 1, 2009, Pages 60-71

  Ghosh, Mimi ^a   Shen, Zheng ^a   Schaefer, Todd M ^a   Fahey, John V ^a   Gupta, Phalguni ^b   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; CCL20 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INCUBATION TIME; MACROPHAGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UTERINE TUBE; VIRUS CELL INTERACTION; CELL CULTURE; DENDRITIC CELL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE; UTERUS; VIROLOGY; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CCL20; DENDRITIC CELLS; EPITHELIAL CELLS; FALLOPIAN TUBES; FEMALE; GENITALIA, FEMALE; HIV-1; HUMANS; POLY I-C; RECOMBINANT PROTEINS; RNA, MESSENGER; UTERUS; VIRUS REPLICATION;

EID: 67149129941     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00713.x     Document Type: Article

References (64)

1. UNAIDS. AIDS epidemic update. http://data.unaids.org/pub/EPISlides/2007/ 2007_epiupdate_en.pdf. 2007.
2. CDC. HIV/AIDS among women. http://www.cdc.gov/hiv/topics/women/resources/ factsheets/pdf/women.pdf. 2007.
3. Ndesendo VM, Pillay V, Choonara YE, Buchmann E, Bayever DN, Meyer LC: A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech 2008; 9: 505 -520.
4. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357: 1149-1153.
5. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-1409.
6. Johnston MI, Fauci AS: An HIV vaccine -evolving concepts. N Engl J Med 2007; 356: 2073-2081.
7. Fahey JV, Wira CR: Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185: 1606-1613.
8. Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC, Chen HY, Landay A: Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol 2007; 14: 1102-1107.
9. Schaefer TM, Fahey JV, Wright JA, Wira CR: Innate immunity in the human female reproductive tract: Antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 2005; 174: 992-1002.
10. Cole AM: Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol 2006; 306: 199-230.
11. Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC: PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. Aids 2007; 21: 467-476.
12. Moutsopoulos NM, Greenwell-Wild T, Wahl SM: Differential mucosal susceptibility in HIV-1 transmission and infection. Adv Dent Res 2006; 19: 52-56.
13. Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T: Role of beta-defensins in oral epithelial health and disease. Med Mol Morphol 2007; 40: 179-184.
14. Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T: Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 2002; 169: 6985-6991.
15. Hiemstra PS: The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33: 537-542.
16. Wollenberg A, Klein E: Current aspects of innate and adaptive immunity in atopic dermatitis. Clin Rev Allergy Immunol 2007; 33: 35-44.
17. Wehkamp J, Schmid M, Stange EF: Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23: 370-378.
18. Ghosh M, Schaefer TM, Fahey JV, Wright JA, Wira CR: Antiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C). Fertil Steril 2008; 89 (5 Suppl.): 1497-1506.
19. King AE, Critchley HO, Kelly RW: Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003; 1: 116.
20. Venkataraman N, Cole AL, Svoboda P, Pohl J, Cole AM: Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol 2005; 175: 7560-7567.
21. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ: Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003; 74: 448-455.
22. Linge HM, Collin M, Nordenfelt P, Morgelin M, Malmsten M, Egesten A: The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother 2008; 52: 2599-2607.
23. Linge HM, Collin M, Giwercman A, Malm J, Bjartell A, Egesten A: The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma. J Interferon Cytokine Res 2008; 28: 191-196.
24. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM: CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999; 162: 186-194.
25. Schutyser E, Struyf S, Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003; 14: 409-426.
26. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC: Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 2002; 51: 818-826.
27. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T: Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003; 28: 648-654.
28. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, Romani N, Heufler C: Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 2002; 11: 135-142.
29. Sun B, Nasu K, Fukuda J, Mine S, Nishida M, Miyakawa I: Expression of macrophage inflammatory protein-3alpha in an endometrial epithelial cell line, HHUA, and cultured human endometrial stromal cells. Mol Hum Reprod 2002; 8: 930-933.
30. Soboll G, Crane-Godreau MA, Lyimo MA, Wira CR: Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture. Immunology 2006; 118: 185-194.
31. Crane-Godreau MA, Wira CR: CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys. Infect Immun 2005; 73: 476-484.
32. Roxstrom-Lindquist K, Ringqvist E, Palm D, Svard S: Giardia lamblia-induced changes in gene expression in differentiated Caco-2 human intestinal epithelial cells. Infect Immun 2005;73: 8204-8208.
33. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 998-1005.
34. Berlier W, Cremel M, Hamzeh H, Levy R, Lucht F, Bourlet T, Pozzetto B, Delezay O: Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: Involvement in the sexual transmission of HIV. Hum Reprod 2006; 21: 1135-1142.
35. Guess JC, McCance DJ: Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 2005; 79: 14852-14862.
36. Kim BE, Leung DY, Streib JE, Boguniewicz M, Hamid QA, Howell MD: Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol 2007; 119: 457-463.
37. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J: The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002; 277: 37647-37654.
38. Asin SN, Fanger MW, Wildt-Perinic D, Ware PL, Wira CR, Howell AL: Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis 2004; 190: 236-245.
39. Zervomanolakis I, Ott HW, Hadziomerovic D, Mattle V, Seeber BE, Virgolini I, Heute D, Kissler S, Leyendecker G, Wildt L: Physiology of upward transport in the human female genital tract. Ann NY Acad Sci 2007; 1101: 1-20.
40. Fahey JV, Prabhala RH, Guyre PM, Wira CR: Antigen-presenting cells in the human female reproductive tract: Analysis of antigen presentation in pre- and post-menopausal women. Am J Reprod Immunol 1999; 42: 49-57.
41. Fahey JV, Humphrey SL, Stern JE, Wira CR: Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol Invest 1998; 27: 167-180.
42. Wallace PK, Yeaman GR, Johnson K, Collins JE, Guyre PM, Wira CR: MHC class II expression and antigen presentation by human endometrial cells. J Steroid Biochem Mol Biol 2001; 76: 203-211.
43. Richardson JM, Kaushic C, Wira CR: Polymeric immunoglobin (Ig) receptor production and IgA transcytosis in polarized primary cultures of mature rat uterine epithelial cells. Biol Reprod 1995; 53: 488-498.
44. Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, Gray JW, Jensen RH: Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2000; 2: 84-91.
45. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002; 46: 1896-1905.
46. Amella CA, Sherry B, Shepp DH, Schmidtmayerova H: Macrophage inflammatory protein 1alpha inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP. J Virol 2005; 79: 5625-5631.
47. Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyot N, Zani ML: Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 2008; 90: 284-295.
48. Fahey JV, Schaefer TM, Channon JY, Wira CR: Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 2005; 20: 1439-1446.
49. Kunz G, Noe M, Herbertz M, Leyendecker G: Uterine peristalsis during the follicular phase of the menstrual cycle: Effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update 1998; 4: 647-654.
50. Kunz G, Beil D, Deiniger H, Einspanier A, Mall G, Leyendecker G: The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 1997; 424: 267-277.
51. Kotronias D, Kapranos N: Detection of herpes simplex virus DNA in human spermatozoa by in situ hybridization technique. In Vivo 1998; 12: 391-394.
52. Hadchouel M, Scotto J, Huret JL, Molinie C, Villa E, Degos F, Brechot C: Presence of HBV DNA in spermatozoa: A possible vertical transmission of HBV via the germ line. J Med Virol 1985; 16: 61-66.
53. Piomboni P, Baccetti B: Spermatozoon as a vehicle for HIV-1 and other viruses: A review. Mol Reprod Dev 2000; 56 (2 Suppl.): 238-242.
54. Bandivdekar AH, Velhal SM, Raghavan VP: Identification of CD4-independent HIV receptors on spermatozoa. Am J Reprod Immunol 2003; 50: 322-327.
55. Cremel M, Hamzeh-Cognasse H, Genin C, Delezay O: Female genital tract immunization: Evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation. Vaccine 2006; 24: 5744-5754.
56. Garzino-Demo A: Chemokines and defensins as HIVAsuppressive factors: an evolving story. Curr Pharm Des 2007; 13: 163-172.
57. Singh PK, Tack BF, McCray PB Jr, Welsh MJ: Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279: L799-L805.
58. Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H: Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 2005; 40: 123-132.
59. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL: Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 2006; 20: 2068-2080.
60. Shaw JL, Diamandis EP: A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology. Biol Chem 2008; 389: 681-688.
61. Ajami K, Pitman MR, Wilson CH, Park J, Menz RI, Starr AE, Cox JH, Abbott Ca, Overall CM, Gorrell MD: Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett 2008; 582: 819-825.
62. Wolf M, Albrecht S, Marki C: Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 2008; 40: 1185-1198.
63. Guan E, Wang J, Norcross MA: Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV. J Cell Biochem 2004; 92: 53-64.
64. Weinberg A, Quinones-Mateu ME, Lederman MM: Role of human beta-defensins in HIV infection. Adv Dent Res2006; 19: 42-48.